Phio Pharmaceuticals Corp. (PHIO): Total Assets
$21.49M
As of 2025-12-31
$14.31M
As of 2026-06-30
+18.8%
3-year compound annual growth
+6.4%
5-year compound annual growth
+6.8%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $21.49M | +274.5% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $5.74M | -38.7% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $9.36M | -26.9% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $12.81M | -49.1% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $25.17M | +59.9% | 2023-03-22, Balance as of period end |
| 2020-12-31 | $15.74M | +95.8% | 2022-03-22, Balance as of period end |
| 2019-12-31 | $8.04M | -47.5% | 2021-03-25, Balance as of period end |
| 2018-12-31 | $15.32M | +273.9% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $4.10M | -69.4% | 2019-03-27, Balance as of period end |
| 2016-12-31 | $13.40M | +20.1% | 2018-03-26, Balance as of period end |
| 2015-12-31 | $11.16M | +21.4% | 2017-03-30, Balance as of period end |
| 2014-12-31 | $9.19M | -38.5% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $14.94M | +167.1% | 2015-03-30, Balance as of period end |
| 2012-12-31 | $5.59M | +230.1% | 2014-03-28, Balance as of period end |
| 2011-12-31 | $1.69M | n/a | 2013-03-29, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | 2025-12-31 | $21.49M | +274.5% |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | $21.44M | -9.2% |
| BriaCell Therapeutics Corp. (BCTX) | 2025-07-31 | $21.65M | +268.7% |
| Annovis Bio, Inc. (ANVS) | 2025-12-31 | $21.08M | +51.4% |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | $21.06M | +179.3% |
| Moleculin Biotech, Inc. (MBRX) | 2025-12-31 | $22.13M | +30.7% |
| Jyong Biotech Ltd. (MENS) | 2025-12-31 | $20.78M | +226.4% |
| Nexentis Technologies Inc. (NXTS) | 2025-12-31 | $20.41M | +273.4% |
| Quoin Pharmaceuticals Ltd. (QNRX) | 2025-12-31 | $20.39M | +29.8% |
Compare PHIO, EMMA, BCTX, ANVS side by side · Screen every company in Pharmaceutical Preparations ↗